Pharmacological Intervention for Symptomatic Snoring

NCT03720353 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Snoring

Interventions

DRUG: SAS2094AH and SAS2094BH
DRUG: SAS2094AL and SAS2094BL
DRUG: Placebo

Sponsor

Brigham and Women's Hospital